J Timothy Stout

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Research Development Foundation, Oregon Health & Science University. Active years: 2006-2021.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 30.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Houston, TX (US) (2017 - 2018)
Portland, OR (US) (2006 - 2021)

Company Filing History:

8 out of 299

Research Development Foundation

patents

4 out of 524

Oregon Health & Science University

patents

where one patent can have more than one assignee

Years Active: 2006-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098097 - Recombinant filaggrin polypeptides for cell importation (2021-08-24),

2. 10336797 - Recombinant filaggrin polypeptides for cell importation (2019-07-02),

3. 10070784 - OCT vitrectomy probe (2018-09-11),

4. 9937269 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2018-04-10),

5. 9650426 - RTEF-1 variants and uses thereof (2017-05-16),

6. 9512423 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2016-12-06),

7. 8785385 - RTEF-1 variants and uses thereof (2014-07-22),

8. 8748379 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2014-06-10),

9. 7557197 - Human soluble neuropilin-1 primary polyadenylation signal and uses thereof (2009-07-07),

10. 7122181 - Lentiviral vector-mediated gene transfer and uses thereof (2006-10-17),

Title: J Timothy Stout: Innovator in Recombinant Polypeptides

Introduction

J Timothy Stout is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 10 patents to his name, Stout's work has implications for treating skin diseases and disorders.

Latest Patents

One of Stout's latest patents focuses on recombinant filaggrin polypeptides for cell importation. This invention discloses recombinant polypeptides that include a filaggrin amino acid sequence and a cell importation signal sequence. The signal sequence contains a motif of two to fifteen amino acids, which includes at least one arginine residue and at least one methionine residue. Additionally, the patent covers nucleic acids encoding these recombinant polypeptides, as well as compositions that incorporate them. Methods for treating or preventing skin diseases using these compositions are also included, along with kits that contain the recombinant polypeptides.

Career Highlights

Throughout his career, J Timothy Stout has worked with various organizations, including the Research Development Foundation and Oregon Health & Science University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Stout has collaborated with notable colleagues such as Binoy Appukuttan and Trevor McFarland. These partnerships have likely enriched his research and led to innovative developments in his field.

Conclusion

J Timothy Stout's contributions to biotechnology, particularly in recombinant polypeptides, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving treatments for skin disorders.